Article Text

Time to standardise dry cow therapy terminology
  1. Eric Hillerton, BSc, PhD1,
  2. Mark Bryan, BVMS, MACVSc(Epi), MVS (Epi)2,
  3. Andrew Biggs, BVSc, MRCVS3,
  4. Elizabeth Berry, BVSc, PhD, MRCVS4 and
  5. Peter Edmondson, MVB, CertCHP, DipECBHM, FRCVS5
  1. 1163 Flume Road, Cambridge 3496, New Zealand; e-mail:
  2. 2VetSouth, Winton, New Zealand
  3. 3The Vale Veterinary Group, The Laurels, Tiverton, Devon EX16 4LF, UK
  4. 4Ryelands, Upton Bishop, Herefordshire HR9 7TU, UK
  5. 5Udder Wise, East Pennard, Shepton Mallet, Somerset BA4 6UF, UK

Statistics from

FOR 45 years, infusing a long-acting antimicrobial preparation into each teat of a dairy cow at the end of lactation has been one of the most important tools in the National Institute for Research in Dairying/Central Veterinary Laboratory (NIRD/CVL) five-point management strategy to minimise intramammary infections. The strategy has been widely adopted internationally, aimed at both treatment of, and protection from, intramammary infections. The success can be measured in the reduction of national herd bulk milk cell counts from in excess of one million cells/ml in the mid-1960s to values commonly around 150,000 cell/ml annual average or less today (for example, Booth 1988, AHDB 2017). More importantly, the prevalence of intramammary infection at the end of lactation has fallen from around 60 per cent to as low as 10 to 20 per cent of cows, varying with herd, farming system and even country (Wilson and Kingwill 1975, Bradley and others 2007, Hillerton 2017).

As a consequence of the reduced prevalence of intramammary infections at drying off, the routine use of antibiotic dry cow therapy is no longer required …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.